Lv12
4 积分 2025-08-30 加入
Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial
11小时前
待确认
Nivolumab plus Ipilimumab in MicrosatelliteInstability–High Metastatic Colorectal Cancer
1天前
已完结
Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial
3天前
已完结
Cetuximab for the treatment of colorectal cancer
1个月前
已完结
Cetuximab for the treatment of colorectal cancer
1个月前
已关闭
Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer
3个月前
已完结
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
3个月前
已完结
Evaluation of the efficacy and safety of first- and second-line immunotherapy in patients with metastatic colorectal cancer: a systematic review and network meta-analysis based on randomized controlled trials
3个月前
已完结
Adrenomedullin/ FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis
3个月前
已完结
Behavioral Intervention with Eye-Use Monitoring to Delay Myopia Onset and Progression in Children
3个月前
已完结
皖公网安备34019202002308
